Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective

Marisa Di Pietro1, Simone Filardo2, Silvio Romano3

  • 1Department of Public Health and Infectious Diseases, Section of Microbiology, University of Rome "Sapienza", 00185 Rome, Italy. marisa.dipietro@uniroma1.it.

Microorganisms
|May 19, 2019
PubMed

Insights

Recent advances enhance understanding of Chlamydia pathogenesis. This review covers Chlamydia trachomatis in STDs and Chlamydia pneumoniae in chronic inflammatory diseases, focusing on host-pathogen interactions.

Area of Science:

  • Microbiology and Immunology
  • Pathogen Biology
  • Molecular Biology

Background:

  • Chlamydia trachomatis is a leading cause of bacterial sexually transmitted diseases, causing cervicitis and urethritis.
  • Chlamydia pneumoniae is a respiratory pathogen linked to chronic inflammatory diseases.
  • Advances in molecular biology, including metagenomics and genomic transformation, are improving Chlamydia research.

Purpose of the Study:

  • To review current evidence on Chlamydia trachomatis and host defense in the genital tract.
  • To summarize key findings regarding Chlamydia pneumoniae and its association with chronic inflammatory diseases.
  • To highlight the complex interplay between Chlamydia species and host factors.

Main Methods:

  • Literature review of recent research on Chlamydia pathogenesis.
  • Analysis of studies on host-pathogen interactions in genital and respiratory tracts.
  • Synthesis of data on molecular mechanisms and clinical associations.

Main Results:

  • Chlamydia trachomatis pathogenesis is better understood through new molecular techniques.
  • The interplay between Chlamydia trachomatis and host defenses in the genital environment is complex.
  • Chlamydia pneumoniae is significantly associated with various chronic inflammatory conditions.

Conclusions:

  • Enhanced understanding of Chlamydia pathogenesis is crucial for developing new therapeutic strategies.
  • Further research into host-pathogen interactions is needed for both Chlamydia trachomatis and Chlamydia pneumoniae.
  • Chlamydia species represent significant public health concerns requiring continued investigation.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
449
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
797
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.8K
Predator-Prey Interactions02:39

Predator-Prey Interactions

Predators consume prey for energy. Predators that acquire prey and prey that avoid predation both increase their chances of survival and reproduction (i.e., fitness). Routine predator-prey interactions elicit mutual adaptations that improve predator offenses, such as claws, teeth, and speed, as well as prey defenses, including crypsis, aposematism, and mimicry. Thus, predator-prey interactions resemble an evolutionary arms race.
21.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
784
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K